Evidence map›Paper›PMID 42157240›Full record

SynthesisBMC women's health2026

Same-day long-acting reversible contraceptive (LARC) placement: a systematic review of the benefits and barriers in the United States.

Greta Lozano-Ortega, Andrew R Kennedy, Simone Crespi, Vanessa Perez Patel

Abstract readSystematic Review
In one paragraph

Synthesis in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Greta Lozano-OrtegaBroadstreet HEOR, 201-343 Railway St, Vancouver, BC, Canada. glozano-ortega@broadstreetheor.com.
Andrew R KennedyBroadstreet HEOR, 201-343 Railway St, Vancouver, BC, Canada.
Simone CrespiOrganon & Co, Jersey City, NJ, USA.
Vanessa Perez PatelOrganon & Co, Jersey City, NJ, USA.

Funding

Organon & Co. n/a
6 · The paper itself

Abstract

backgroundIncreasing same-day placement rates of long-acting reversible contraceptives (LARCs) for individuals who are medically eligible and desire to do so is a key component of contraceptive access. The objective of this literature review was to characterize data on the effectiveness and economic impact of programs aimed at increasing same-day LARC placement in the United States (US).

methodsA systematic literature review was conducted January 2023 to identify relevant literature from 2012 onwards using Medline, EMBASE, and CINAHL databases. Studies reporting rates of same-day LARC placement, economic benefits related to specific programs or policies, or factors affecting access to same-day LARC placement were included. Key recommendations, including actionable insights to improve access to same-day LARC, were summarized.

resultsThirty-three publications, representing 31 unique studies investigating same-day LARC placement across 21 states were included. Seven studies evaluated outcomes pre- and post-implementation of programs for same-day LARC placement, and all reported an increase in the rate of same-day LARC placements post-program implementation. Two studies estimated cost savings (USD) associated with same-day LARC placement, one estimated savings of $2,117 per adolescent per year when compared to requiring a second visit, and the second estimated savings of approximately $80 million through an assumed statewide scale-up of the evaluated program. Actionable insights to promote same-day LARC placement included staff and provider training, streamlining pregnancy and screening requirements, increasing LARC availability, and providing financial assistance.

conclusionsPrograms for increasing same-day LARC placement were associated with increases in same-day LARC uptake and cost savings.

Indexed as

Health Services AccessibilityLong-Acting Reversible ContraceptionCost-Benefit AnalysisFemaleHumansPregnancyUnited StatesLARCSame-day long-acting reversible contraceptivesSystematic literature review

Identifiers

PMID42157240
PMCPMC13361743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.